Security key
25253X207
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Voting Common Shares, no par value
- Shares outstanding
- 52,272,727
- Total 13F shares
- 2,524,139
- Share change
- -19,610
- Total reported value
- $3,989,530
- Put/Call ratio
- 6.2%
- Price per share
- $1.58
- Number of holders
- 27
- Value change
- -$6,541
- Number of buys
- 12
- Number of sells
- 8
Report period
Q4 2022
Institutions
27
Top holders
10
DMAC full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
DiaMedica Therapeutics Inc. SEC filings
DiaMedica Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25253X207
Recent filing periods:
Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Leon G. Cooperman |
13F
|
Individual |
1.6%
|
812,508
|
$1,007,510 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
782,640
|
$971,000 | — | 30 Sep 2022 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.46%
|
238,500
|
$296,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
185,219
|
$229,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
90,254
|
$112,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.13%
|
68,870
|
$85,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
66,629
|
$83,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
53,007
|
$66,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
42,634
|
$53,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
36,248
|
$45,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
35,258
|
$44,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
34,912
|
$43,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
24,900
|
$31,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
14,518
|
$18,000 | — | 30 Sep 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.02%
|
10,441
|
$12,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
10,003
|
$12,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
7,191
|
$9,000 | — | 30 Sep 2022 | |
| MassMutual Private Wealth & Trust, FSB |
13F
|
Company |
0.01%
|
4,824
|
$6,000 | — | 30 Sep 2022 | |
| US BANCORP \DE\ |
13F
|
Company |
0.01%
|
4,335
|
$5,000 | — | 30 Sep 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
2,005
|
$2,000 | — | 30 Sep 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
1,570
|
$2,410 | — | 30 Sep 2022 | |
| Legend Financial Advisors, Inc. |
13F
|
Company |
0%
|
1,000
|
$1,240 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
978
|
$1,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
500
|
$1,000 | — | 30 Sep 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
230
|
$285 | — | 30 Sep 2022 | |
| Harry W. Alcorn Jr. |
3/4/5
|
SVP, Clinical Operations |
—
class O/S missing
|
43,981
|
$123,147 | — | 15 Sep 2021 | |
| Sydney A. Gilman |
3/4/5
|
VP, Regulatory Affairs |
—
class O/S missing
|
25,000
|
— | — | 28 Jul 2021 |
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2022
As of 31 Dec 2022,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,524,139 shares.
The largest 10 holders included
COOPERMAN LEON G, VANGUARD GROUP INC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BlackRock Inc., STATE STREET CORP, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and CITADEL ADVISORS LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
23
Q4 2022 holders
27
Holder diff
4
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.